DURECT Corp. (DRRX)

0.67
0.02 3.09
NASDAQ : Health Technology
Prev Close 0.70
Open 0.70
Day Low/High 0.67 / 0.71
52 Wk Low/High 0.46 / 1.66
Volume 266.48K
Avg Volume 929.40K
Exchange NASDAQ
Shares Outstanding 191.36M
Market Cap 131.98M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)
Business Highlights

Business Highlights

Business Highlights

Durect Stock Gaps Down On Today's Open (DRRX)

Durect Stock Gaps Down On Today's Open (DRRX)

Shares of Durect Corporation (Nasdaq:DRRX) were gapping down Friday morning with an open price 25.6% lower than Thursday's closing price. The stock closed at $3.09 yesterday and opened today's trading at $2.30.

Pfizer, Pain Therapeutics Drug Rejected by FDA

Pfizer, Pain Therapeutics Drug Rejected by FDA

Pfizer and Pain Therapeutics have been trying to get Remoxy, a tamper-resistant painkiller, approved for three years.

10 Stocks to Watch: Alcoa, BP

10 Stocks to Watch: Alcoa, BP

Alcoa's first-quarter earnings squeaked past Wall Street expectations, but its top line missed analysts' estimates.

Biotech Calendar: 2011 FDA Drug Approvals

Biotech Calendar: 2011 FDA Drug Approvals

An updated list of drug and biotech firms with drug approvals expected in 2011.

DURECT Corporation Q1 2010 Earnings Call Transcript

DURECT Corporation Q1 2010 Earnings Call Transcript

Durect Says Pain Patch Met Goals In Clinical Study

Durect says Transdur Sufentanil reduced pain and met safety goals in midstage clinical trial

Thursday's Winners & Losers: Durect

Shares shoot up 19% after earnings.

Health Winners & Losers: Barr

Barr Pharma slides on an earnings miss.

Three Biotechs Join Stocks Under $10 Watch List

Three Biotechs Join Stocks Under $10 Watch List

Keeping an eye on Seattle Genetics, Dynavax Technologies and Durect.

Three Stocks Under $10 to Watch

See what companies our team is considering for the Stocks Under $10 portfolio.

Patient Investors Should Profit

Despite dismal economic data and the threat of inflation, these three names in the under-$10 space are becoming very attractive.

Opportunities Arising

With many of the stocks on our Watch List trading lower, we plan to commit some cash to new positions.

Tuesday's Health Winners & Losers

Tuesday's Health Winners & Losers

Cortex Pharma climbs on greenlight from the FDA for an Alzheimer's trial.

Durect Deposit

The stock soars on a Nycomed tie-up.

Tuesday's Health Winners & Losers

Tuesday's Health Winners & Losers

Arena Pharmaceuticals is rising.

Friday's Health Winners & Losers

Friday's Health Winners & Losers

Durect is higher, but AstraZeneca falls.

Tuesday's Small-Cap Winners & Losers

Tuesday's Small-Cap Winners & Losers

Sonic Automotive rises after an upgrade.

Health Stocks in Motion

Health Stocks in Motion

Wellcare surges after its third-quarter earnings and fourth-quarter guidance top views.

Health Stocks in Motion

Health Stocks in Motion

Durect rises after licensing pain-relief patch to Endo.

TheStreet Quant Rating: D- (Sell)